{"DataElement":{"publicId":"14429697","version":"1","preferredName":"Cell of Origin Lymphoma Subtype","preferredDefinition":"The cell of origin (COO) lymphoma subtype.","longName":"14429691v1.00:14429694v1.00","context":"AMC","contextVersion":"1","DataElementConcept":{"publicId":"14429691","version":"1","preferredName":"Cell of Origin Subtype Lymphoma","preferredDefinition":"The normal cell in which mutation leads to the initiation of a neoplastic process.:A group forming a type within a larger type._A malignant (clonal) proliferation of B- lymphocytes or T- lymphocytes which involves the lymph nodes, bone marrow and/or extranodal sites. This category includes Non-Hodgkin lymphomas and Hodgkin lymphomas.","longName":"14429692v1.00:14429693v1.00","context":"AMC","contextVersion":"1","ObjectClass":{"publicId":"14429692","version":"1","preferredName":"Cell of Origin","preferredDefinition":"The normal cell in which mutation leads to the initiation of a neoplastic process.","longName":"C201094","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Cell of Origin","conceptCode":"C201094","definition":"The normal cell in which mutation leads to the initiation of a neoplastic process.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"03CA7FF8-3A2B-471B-E063-731AD00AB79B","latestVersionIndicator":"Yes","beginDate":"2023-08-25","endDate":null,"createdBy":"TSESU","dateCreated":"2023-08-25","modifiedBy":"TSESU","dateModified":"2023-08-25","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"14429693","version":"1","preferredName":"Subtype Lymphoma","preferredDefinition":"A group forming a type within a larger type._A malignant (clonal) proliferation of B- lymphocytes or T- lymphocytes which involves the lymph nodes, bone marrow and/or extranodal sites. This category includes Non-Hodgkin lymphomas and Hodgkin lymphomas.","longName":"C25696:C3208","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Subtype","conceptCode":"C25696","definition":"A group forming a type within a larger type.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Lymphoma","conceptCode":"C3208","definition":"A malignant (clonal) proliferation of B- lymphocytes or T- lymphocytes which involves the lymph nodes, bone marrow and/or extranodal sites. This category includes Non-Hodgkin lymphomas and Hodgkin lymphomas.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"03CA7FF8-3A2C-471B-E063-731AD00AB79B","latestVersionIndicator":"Yes","beginDate":"2023-08-25","endDate":null,"createdBy":"TSESU","dateCreated":"2023-08-25","modifiedBy":"TSESU","dateModified":"2023-08-25","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008551","version":"1","preferredName":"Assessments","preferredDefinition":"evaluations of the patient and the patient's disease.","longName":"ASSESS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B22DA727-6718-5A2D-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-19","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-19","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"03CA77EA-6DF0-461F-E063-731AD00A534A","latestVersionIndicator":"Yes","beginDate":"2023-08-25","endDate":null,"createdBy":"TSESU","dateCreated":"2023-08-25","modifiedBy":"TSESU","dateModified":"2024-01-11","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"14429694","version":"1","preferredName":"Lymphoma Subtype Type","preferredDefinition":"A malignant (clonal) proliferation of B- lymphocytes or T- lymphocytes which involves the lymph nodes, bone marrow and/or extranodal sites. This category includes Non-Hodgkin lymphomas and Hodgkin lymphomas._A group forming a type within a larger type._Something distinguishable as an identifiable class based on common qualities.","longName":"14429694v1.00","context":"AMC","contextVersion":"1","type":"Enumerated","dataType":"NUMBER","minLength":null,"maxLength":null,"minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"1","valueDescription":null,"ValueMeaning":{"publicId":"14429695","version":"1","preferredName":"Germinal Center","longName":"14429695v1.00","preferredDefinition":"Sites in secondary lymphoid tissue where follicular dendritic cells present antigens to B-cells and follicular helper T-cells.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Germinal Center","conceptCode":"C13337","definition":"Sites in secondary lymphoid tissue where follicular dendritic cells present antigens to B-cells and follicular helper T-cells.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"03CA95D6-345F-494D-E063-731AD00AB6A7","latestVersionIndicator":"Yes","beginDate":"2023-08-25","endDate":null,"createdBy":"TSESU","dateCreated":"2023-08-25","modifiedBy":"TSESU","dateModified":"2023-08-25","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"03CA95D6-3461-494D-E063-731AD00AB6A7","beginDate":"2023-08-25","endDate":null,"createdBy":"TSESU","dateCreated":"2023-08-25","modifiedBy":"TSESU","dateModified":"2023-08-25","deletedIndicator":"No"},{"value":"2","valueDescription":null,"ValueMeaning":{"publicId":"10497045","version":"1","preferredName":"Nongerminomatous Germ Cell Tumor","longName":"10497045v1.00","preferredDefinition":"A term that refers to teratoma, embryonal carcinoma, yolk sac tumor, choriocarcinoma, or mixed forms of these tumors.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Nongerminomatous Germ Cell Tumor","conceptCode":"C121619","definition":"A term that refers to teratoma, embryonal carcinoma, yolk sac tumor, choriocarcinoma, or mixed forms of these tumors.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"E17E3623-9386-491A-E053-731AD00A0CC1","latestVersionIndicator":"Yes","beginDate":"2022-06-22","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2022-06-22","modifiedBy":"KUMMEROA","dateModified":"2022-06-22","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"03CA95D6-3462-494D-E063-731AD00AB6A7","beginDate":"2023-08-25","endDate":null,"createdBy":"TSESU","dateCreated":"2023-08-25","modifiedBy":"TSESU","dateModified":"2023-08-25","deletedIndicator":"No"},{"value":"3","valueDescription":null,"ValueMeaning":{"publicId":"14429696","version":"1","preferredName":"Indeterminate Or Not Done","longName":"14429696v1.00","preferredDefinition":"Cannot distinguish between two or more possible values in the current context._An article used to connect words, phrases, or clauses representing alternatives; used to connect alternative terms for the same thing; used in correlation; used to correct or rephrase what was previously said; otherwise._Indicates a task, process or examination that has either not been initiated or not been completed.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Indeterminate","conceptCode":"C48658","definition":"Cannot distinguish between two or more possible values in the current context.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Or","conceptCode":"C37998","definition":"An article used to connect words, phrases, or clauses representing alternatives; used to connect alternative terms for the same thing; used in correlation; used to correct or rephrase what was previously said; otherwise.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Not Done","conceptCode":"C49484","definition":"Indicates a task, process or examination that has either not been initiated or not been completed.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"03CA95D6-3460-494D-E063-731AD00AB6A7","latestVersionIndicator":"Yes","beginDate":"2023-08-25","endDate":null,"createdBy":"TSESU","dateCreated":"2023-08-25","modifiedBy":"TSESU","dateModified":"2023-08-25","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"03CA95D6-3463-494D-E063-731AD00AB6A7","beginDate":"2023-08-25","endDate":null,"createdBy":"TSESU","dateCreated":"2023-08-25","modifiedBy":"TSESU","dateModified":"2023-08-25","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008551","version":"1","preferredName":"Assessments","preferredDefinition":"evaluations of the patient and the patient's disease.","longName":"ASSESS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B22DA727-6718-5A2D-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-19","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-19","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"14429699","version":"1","preferredName":"Subtype Lymphoma Type","preferredDefinition":"A group forming a type within a larger type._A malignant (clonal) proliferation of B- lymphocytes or T- lymphocytes which involves the lymph nodes, bone marrow and/or extranodal sites. This category includes Non-Hodgkin lymphomas and Hodgkin lymphomas._Something distinguishable as an identifiable class based on common qualities.","longName":"14429699v1.00","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Subtype","conceptCode":"C25696","definition":"A group forming a type within a larger type.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Lymphoma","conceptCode":"C3208","definition":"A malignant (clonal) proliferation of B- lymphocytes or T- lymphocytes which involves the lymph nodes, bone marrow and/or extranodal sites. This category includes Non-Hodgkin lymphomas and Hodgkin lymphomas.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Type","conceptCode":"C25284","definition":"Something distinguishable as an identifiable class based on common qualities.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"03CACFD0-0E1C-52C8-E063-731AD00AA4FC","latestVersionIndicator":"Yes","beginDate":"2023-08-25","endDate":null,"createdBy":"TSESU","dateCreated":"2023-08-25","modifiedBy":"TSESU","dateModified":"2023-08-25","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"DRAFT NEW","registrationStatus":"Application","id":"03CA8ECF-39D1-489E-E063-731AD00A38D8","latestVersionIndicator":"Yes","beginDate":"2023-08-25","endDate":null,"createdBy":"TSESU","dateCreated":"2023-08-25","modifiedBy":"TSESU","dateModified":"2023-08-25","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[],"AlternateNames":[{"name":"COO_SUBTYPE","type":"OID, AMC","context":"AMC"}],"ReferenceDocuments":[{"name":"PQT","type":"Preferred Question Text","description":"The cell of origin (COO) lymphoma subtype","url":null,"context":"AMC"},{"name":"AMC CRF Text 1","type":"Alternate Question Text","description":"Cell of origin (COO) lymphoma subtype (by local pathology)","url":null,"context":"AMC"}],"origin":null,"workflowStatus":"DRAFT NEW","registrationStatus":"Application","id":"03CA9DDF-7871-4A20-E063-731AD00A61A8","latestVersionIndicator":"Yes","beginDate":"2023-08-25","endDate":null,"createdBy":"TSESU","dateCreated":"2023-08-25","modifiedBy":"TSESU","dateModified":"2023-08-28","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}